Back to Search
Start Over
Major reduction of NKT cells in patients with severe COVID-19 pneumonia.
- Source :
-
Clinical Immunology . Jan2021, Vol. 222, pN.PAG-N.PAG. 1p. - Publication Year :
- 2021
-
Abstract
- NK cells seem to be mainly involved in COVID-19 pneumonia. Little is known about NKT cells which represent a bridge between innate and adaptive immunity. We characterized peripheral blood T, NK and NKT cells in 45 patients with COVID-19 pneumonia (COVID-19 subjects) and 19 healthy donors (HDs). According to the severity of the disease, we stratified COVID-19 subjects into severe and non-severe groups. Compared to HDs, COVID-19 subjects showed higher percentages of NK CD57+ and CD56dim NK cells and lower percentages of NKT and CD56bright cells. In the severe group we found a significantly lower percentage of NKT cells. In a multiple logistic regression analysis, NKT cell was independently associated with the severity of the disease. The low percentage of NKT cells in peripheral blood of COVID-19 subjects and the independent association with the severity of the disease suggests a potential role of this subset. Unlabelled Image • High percentages of NK CD57+ cells and CD56dimNK cells in COVID-19 subjects • Low percentages of CD56bright and NKT cells in COVID-19 subjects • Severe COVID-19 pneumonia and NKT cell reduction were independently associated [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 15216616
- Volume :
- 222
- Database :
- Academic Search Index
- Journal :
- Clinical Immunology
- Publication Type :
- Academic Journal
- Accession number :
- 148141738
- Full Text :
- https://doi.org/10.1016/j.clim.2020.108630